Clinical Trials Directory

Trials / Unknown

UnknownNCT04353323

COVID 19-Caregivers IGg Seroconversion

Comparison of the Proportion of Covid19 Seroconversion of Caregivers Working or Not in the COVID Sector

Status
Unknown
Phase
Study type
Observational
Enrollment
130 (estimated)
Sponsor
University Hospital, Limoges · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

According to recent publications, the percentage of caregivers infected with COVID 19 is evaluated between 10 and 30% . This great variability is due, on the one hand to the intensity of the influx of covid plus patients and, on the other hand, to the disparity in the preparation of caregivers in the face of this emergency. Indeed, we can understand that the strict application of hygiene rules can be faulted in the face of the volume of patients, the lack of protective equipment and the lack of specific training for caregivers in this area. As a result, within healthcare teams, there are many questions that generate anxiety: will I be able to provide care properly while protecting myself from the risk of contamination? This anxiety is also present and sometimes manifests itself aggressively in the entourage or in the vicinity of caregivers, due to lack of scientific data adapted to the local ecology of the crisis. Thus, the aim of this study is to show that the risk for caregivers of being contaminated by COVID in an area dedicated to COVID positive patients is no higher than being a caregiver in a non-COVID area that he either in the adult or pediatric sector.

Conditions

Interventions

TypeNameDescription
OTHERBlood sampling3 blood samples (D0, D15 and D30) will be taken from each participant

Timeline

Start date
2020-05-25
Primary completion
2020-06-25
Completion
2020-12-25
First posted
2020-04-20
Last updated
2020-05-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04353323. Inclusion in this directory is not an endorsement.